- Daratumumab in dialysis-dependent multiple myeloma
-
Jeyaraman , Bhasin A, Dayal N, Pathak S, Naithani R
- KMID: 2472011
- Blood Res.
- 2020 Mar;55(1):65-67.
- doi: 10.5045/br.2020.55.1.65
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma
-
Kim JG, Kim HR, You MH, Shin DH, Choi JS, Bae YK
- KMID: 2467201
- Ann Dermatol.
- 2020 Feb;32(1):53-56.
- doi: 10.5021/ad.2020.32.1.53
Necrobiotic xanthogranuloma (NXG), is a rare multisystem disease that manifests as cutaneous inflammatory lesions, and is commonly associated with lymphoproliferative disease. Diffuse normolipemic plane xanthoma (NX), is also a rare,... -
- CITED
-
- Close
- SHARE
-
- Close
- Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
-
Lee SR, Choi H, Lee BH, Kang KW, Yu ES, Kim DS, Park Y, Choi CW, Kim BS, Sung HJ
- KMID: 2463492
- Korean J Intern Med.
- 2019 Nov;34(6):1333-1346.
- doi: 10.3904/kjim.2018.144
BACKGROUND/AIMS: Bortezomib plus melphalan-prednisone (VMP) is a standard treatment for multiple myeloma, particularly for patients who are ineligible for high-dose therapy. However, early discontinuation or treatment modification is often needed... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimizing carfilzomib use in multiple myeloma treatment
-
Yoon SS
- KMID: 2459377
- Blood Res.
- 2019 Sep;54(3):159-161.
- doi: 10.5045/br.2019.54.3.159
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Cellular immunotherapy in multiple myeloma
-
Vo MC, Lakshmi TJ, Jung SH, Cho D, Park HS, Chu TH, Lee HJ, Kim HJ, Kim SK, Lee JJ
- KMID: 2457017
- Korean J Intern Med.
- 2019 Sep;34(5):954-965.
- doi: 10.3904/kjim.2018.325
In multiple myeloma (MM), the impaired function of several types of immune cells favors the tumor’s escape from immune surveillance and, therefore, its growth and survival. Tremendous improvements have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma
-
Lee HY, Park CJ, Ahn A, Lee MY, Cho YU, Jang S, Seo EJ, Lee KH, Lee JH
- KMID: 2450974
- Ann Lab Med.
- 2019 Sep;39(5):496-498.
- doi: 10.3343/alm.2019.39.5.496
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Angiosarcoma of the Foot Accompanied by Multiple Myeloma: The First Case Report
-
Jo JW, Shin YB, Kwon CI, Kim CY
- KMID: 2457693
- Korean J Dermatol.
- 2019 Aug;57(7):399-402.
Although the exact etiology of cutaneous angiosarcoma remains unclear, MYC gene amplification has been recently discovered as a new pathogenesis. MYC is a proto-oncogene, and aberration of MYC signaling in... -
- CITED
-
- Close
- SHARE
-
- Close
- Simultaneous presentation of plasma cell myeloma and hairy cell leukemia
-
Carulli G, Sammuri P, Ottaviano
- KMID: 2451006
- Blood Res.
- 2019 Jun;54(2):85-85.
- doi: 10.5045/br.2019.54.2.85
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Diffuse Normolipemic Plane Xanthomatosis with Immunoglobulin-Lambda Light-Chain Deposition in a Patient with Multiple Myeloma
-
Lee SH, Shin JY, Lee SH, Park YL
- KMID: 2439077
- Ann Dermatol.
- 2019 Apr;31(2):238-240.
- doi: 10.5021/ad.2019.31.2.238
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Diffuse Normolipemic Plane Xanthoma Associated with Multiple Myeloma
-
Kim WO, Ryoo YW, Kim SA
- KMID: 2446920
- Korean J Dermatol.
- 2019 Mar;57(3):140-144.
Diffuse plane xanthoma (DPX) presents with symmetric yellow-orange plaques primarily on the neck, upper trunk, flexural folds, and the periorbital region. Based on serum lipid and lipoprotein levels, these xanthomas... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Melphalan, Cyclophosphamide and Dexamethasone (MCD) as a Salvage Treatment for Patients with Relapsed/Refractory Multiple Myeloma
-
Lee SS, Lee JJ
- KMID: 2432252
- Chonnam Med J.
- 2019 Jan;55(1):25-30.
- doi: 10.4068/cmj.2019.55.1.25
This study investigated the efficacy and safety of melphalan, cyclophosphamide, and dexamethasone (MCD) as a salvage regimen for heavily treated relapsed or refractory multiple myeloma patients. We retrospectively analyzed a... -
- CITED
-
- Close
- SHARE
-
- Close
- First Case of Plasma Cell Myeloma With Brown Tumor Features Unrelated to Hyperparathyroidism
-
Kim H, Kim K, Cho SR, Kim HJ, Kim SH
- KMID: 2420278
- Ann Lab Med.
- 2019 Jan;39(1):96-98.
- doi: 10.3343/alm.2019.39.1.96
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
-
Park H, Kim DY, Kim SJ, Chung H, Cho H, Jang JE, Cheong JW, Min YH, Song JW, Kim JS
- KMID: 2424785
- Cancer Res Treat.
- 2018 Oct;50(4):1121-1129.
- doi: 10.4143/crt.2017.329
PURPOSE: Although hepatitis B surface antigen (HBsAg)–negative, hepatitis B core antibody (anti-HBc)–negative patients are not considered to be at risk for hepatitis B virus (HBV)–related hepatitis, the actual risk remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma
-
Barrett A, Glavey S, Sargent J, Thornton P, Murphy P, Quinn J
- KMID: 2429328
- Blood Res.
- 2018 Sep;53(3):254-256.
- doi: 10.5045/br.2018.53.3.254
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Multiple myeloma in Korea: risk stratification and initial treatment
-
Yoon SS
- KMID: 2429312
- Blood Res.
- 2018 Sep;53(3):183-184.
- doi: 10.5045/br.2018.53.3.183
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Central Nervous System Involvement in a Patient with Multiple Myeloma Manifesting as an Intraventricular Mass with Leptomeningeal Spread
-
Lee JE, Lee EJ, Huh HJ, Chung JW, Lee EK, Lee HJ
- KMID: 2416406
- J Korean Soc Radiol.
- 2018 Jul;79(1):50-55.
- doi: 10.3348/jksr.2018.79.1.50
Central nervous system involvement in multiple myeloma (CNS-MM) is a rare condition. Various manifestations of CNS-MM have been reported, including dural, parenchymal, and leptomeningeal involvement. Among them, leptomeningeal involvement is... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
-
Lee SE, Jeon YW, Yoon JH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Min CK
- KMID: 2451030
- Blood Res.
- 2018 Jun;53(2):123-129.
- doi: 10.5045/br.2018.53.2.123
BACKGROUND: The aim of this study was to evaluate the effects of darbepoetin alfa (DA) on hemoglobin (Hb) concentration and the need for transfusions in multiple myeloma (MM) patients receiving... -
- CITED
-
- Close
- SHARE
-
- Close
- Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
-
Byun JM, Lee J, Shin SJ, Kang M, Yoon SS, Koh Y
- KMID: 2451027
- Blood Res.
- 2018 Jun;53(2):105-109.
- doi: 10.5045/br.2018.53.2.105
BACKGROUND: High-dose melphalan (HDMEL) represents the standard conditioning regimen before autologous stem cell transplant (ASCT) in multiple myeloma (MM), but recent updates have suggested combination of melphalan with bulsulfan (BUMEL)... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonsecretory Multiple Myeloma Presenting as Recurrent Vertebral Compression Fractures in an Older Male Patient
-
Maeng YH, Hyun CL, Han SH, Seong GM, Song DH, An HJ, Koh HM
- KMID: 2439097
- Ann Geriatr Med Res.
- 2018 Jun;22(2):98-101.
- doi: 10.4235/agmr.2018.22.2.98
Nonsecretory multiple myeloma is a rare variant of multiple myeloma characterized by the proliferation of clonal plasma cells in the bone marrow. It is difficult to establish an early and... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma
-
Lee EM, Kim B
- KMID: 2437850
- Osteoporos Sarcopenia.
- 2018 Jun;4(2):71-74.
- doi: 10.1016/j.afos.2018.05.003
OBJECTIVES: Osteolytic bone lesions are common complications in multiple myeloma (MM), and can have an impact on quality of life due to the risk of fractures. Trabecular bone score (TBS)... -
- CITED
-
- Close
- SHARE
-
- Close
